(Q35039109)

5 August 2017

1 reference

title

The use of proton pump inhibitors in children: a comprehensive review (English)

1 reference

5 August 2017

Troy E Gibbons

1

1 reference

5 August 2017

Benjamin D Gold

series ordinal

2

1 reference

5 August 2017

publication date

1 January 2003

1 reference

5 August 2017

1 reference

5 August 2017

volume

5

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

25-40

1 reference

https://scigraph.springernature.com/pub.10.2165/00128072-200305010-00003

5 August 2017

exact match

0 references

cites work

Omeprazole in infants with cimetidine-resistant peptic esophagitis.

1 reference

12 December 2020

Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole

1 reference

12 December 2020

Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach

1 reference

12 December 2020

1 reference

12 December 2020

Helicobacter pylori Infection in Children: Recommendations for Diagnosis and Treatment

1 reference

12 December 2020

Pharmacogenetics in pediatrics. Implications for practice

1 reference

12 December 2020

Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition

1 reference

12 December 2020

Effect of long-term omeprazole treatment on antral G and D cells in children.

1 reference

12 December 2020

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

1 reference

12 December 2020

Current regimens for treatment of Helicobacter pylori infection

1 reference

12 December 2020

Gastric bacterial overgrowth accompanies profound acid suppression

1 reference

12 December 2020

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

1 reference

12 December 2020

The energy source for gastric H+ secretion.

1 reference

12 December 2020

Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.

1 reference

12 December 2020

Improving on PPI-based therapy of GORD.

1 reference

12 December 2020

Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity

1 reference

12 December 2020

Monoclonal antibodies against gastric H+ + K+ ATPase

1 reference

12 December 2020

Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials

1 reference

12 December 2020

Effects of omeprazole on mechanisms of gastroesophageal reflux in childhood.

1 reference

12 December 2020

CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

1 reference

12 December 2020

One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection

1 reference

12 December 2020

Histological esophagitis: clinical and histological response to omeprazole in children

1 reference

12 December 2020

Omeprazole for severe reflux esophagitis in children

1 reference

12 December 2020

Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.

1 reference

12 December 2020

Omeprazole: therapy of choice in intellectually disabled children

1 reference

12 December 2020

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

1 reference

12 December 2020

Function and structure of parietal cells after H+-K+-ATPase blockade

1 reference

12 December 2020

Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.

1 reference

12 December 2020

Efficacy and safety of omeprazole for severe gastroesophageal reflux in children.

1 reference

12 December 2020

Effective 2-wk therapy for Helicobacter pylori disease in children

1 reference

12 December 2020

Influence of food on the bioavailability of an enteric-coated tablet formulation of omeprazole 20 mg under repeated dose conditions.

1 reference

12 December 2020

Pharmacokinetics of intravenous omeprazole in children

1 reference

12 December 2020

Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children

1 reference

12 December 2020

The role of antisecretory drugs in the treatment of Helicobacter pylori infection

1 reference

12 December 2020

Manifestations of gastroesophageal reflux in the otorhinolaryngology tract

1 reference

12 December 2020

Fundic gland polyps: three other case reports suggesting a possible association with acid suppressing therapy

1 reference

12 December 2020

Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose

1 reference

12 December 2020

Proton pump inhibitors and their drug interactions: an evidence-based approach

1 reference

12 December 2020

Lack of pantoprazole drug interactions in man.

1 reference

12 December 2020

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

1 reference

12 December 2020

Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates

1 reference

12 December 2020

Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue

1 reference

12 December 2020

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

1 reference

12 December 2020

A review of omeprazole use in the treatment of acid-related disorders in children

1 reference

12 December 2020

Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype

1 reference

12 December 2020

Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreas.

1 reference

12 December 2020

1 reference

12 December 2020

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Stability of omeprazole in an extemporaneously prepared oral liquid

1 reference

12 December 2020

A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection

1 reference

12 December 2020

Effect of clarithromycin and other macrolides on the sulfoxidation and 5-hydroxylation of lansoprazole in dogs

1 reference

12 December 2020

Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate

1 reference

12 December 2020

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

1 reference

12 December 2020

Omeprazole reduces preoperative gastric fluid acidity and volume in children.

1 reference

12 December 2020

A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection

1 reference

12 December 2020

Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.

1 reference

12 December 2020

Clinical pharmacokinetics of lansoprazole.

1 reference

12 December 2020

Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole

1 reference

12 December 2020

Helicobacter pylori infection in children: a consensus statement. European Paediatric Task Force on Helicobacter pylori

1 reference

12 December 2020

Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis

1 reference

12 December 2020

Pharmacokinetics of [14C]omeprazole in patients with impaired renal function

1 reference

12 December 2020

Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration

1 reference

12 December 2020

Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status

1 reference

12 December 2020

Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety

1 reference

12 December 2020

Omeprazole for treatment of chronic erosive esophagitis in children: A multicenter study of efficacy, safety, tolerability and dose requirements

1 reference

12 December 2020

A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori

1 reference

12 December 2020

A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

1 reference

12 December 2020

Shortcomings of the first-generation proton pump inhibitors

1 reference

12 December 2020

Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor

1 reference

12 December 2020

Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics

1 reference

12 December 2020

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

12 December 2020

Rabeprazole: pharmacology, pharmacokinetics, and potential for drug interactions. Introduction

1 reference

12 December 2020

Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome

1 reference

12 December 2020

Localization of omeprazole and metabolites in the mouse

1 reference

12 December 2020

Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.

1 reference

12 December 2020

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole

1 reference

12 December 2020

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

1 reference

12 December 2020

Gastric mucosal morphological consequences of acid suppression: a balanced view

1 reference

12 December 2020

Lansoprazole triple therapy for Turkish children with Helicobacter pylori infections

1 reference

12 December 2020

Structural aspects of the gastric H,K ATPase

1 reference

12 December 2020

Pharmacokinetics of lansoprazole in patients with renal or liver disease of varying severity

1 reference

12 December 2020

Dose-response relationship of lansoprazole to gastric acid antisecretory effects

1 reference

12 December 2020

Nocturnal asthma: role of nocturnal gastroesophageal reflux

1 reference

12 December 2020

Safety of proton-pump inhibitors: the acid test.

1 reference

12 December 2020

Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.

1 reference

12 December 2020

One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents

1 reference

12 December 2020

Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori

1 reference

12 December 2020

Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes

1 reference

12 December 2020

Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis.

1 reference

12 December 2020

Populations and genetic polymorphisms

1 reference

12 December 2020

A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients

1 reference

12 December 2020

Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids

1 reference

12 December 2020

Omeprazole produces parietal cell hypertrophy and hyperplasia in humans

1 reference

12 December 2020

Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.

1 reference

12 December 2020

Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group

1 reference

12 December 2020

Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4'-hydroxylation status

1 reference

12 December 2020

Impact of developmental pharmacology on pediatric study design: overcoming the challenges

1 reference

12 December 2020

Omeprazole: the first proton pump inhibitor

1 reference

12 December 2020

Lansoprazole reduces preoperative gastric fluid acidity and volume in children.

1 reference

12 December 2020

Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis

1 reference

12 December 2020

New perspectives in gastric acid suppression: genetic polymorphisms predict the efficacy of proton pump inhibitors

1 reference

12 December 2020

The pharmacology of the gastric acid pump: the H+,K+ ATPase

1 reference

12 December 2020

Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes

1 reference

12 December 2020

Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatment

1 reference

12 December 2020

Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole

1 reference

12 December 2020

The use of omeprazole for resistant oesophagitis in children

1 reference

12 December 2020

Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.

1 reference

12 December 2020

No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux.

1 reference

12 December 2020

Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs

1 reference

12 December 2020

Specific labelling of gastric H+,K+-ATPase by omeprazole

1 reference

12 December 2020

Factors influencing the eradication of Helicobacter pylori with triple therapy

1 reference

12 December 2020

The proton-pump inhibitors: similarities and differences

1 reference

12 December 2020

[Suppression of acid secretion and plasma level of a once-daily dose of omeprazole]

1 reference

12 December 2020

The safety of omeprazole: true or false?

1 reference

12 December 2020

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

1 reference

12 December 2020

Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release

1 reference

12 December 2020

[Individualization of drug therapy and pharmacogenetics]

1 reference

12 December 2020

Delivery of omeprazole and lansoprazole granules through a nasogastric tube in vitro

1 reference

12 December 2020

Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion

1 reference

12 December 2020

K+-stimulated phosphatase of microsomes from gastric mucosa.

1 reference

12 December 2020

Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH.

1 reference

12 December 2020

A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage.

1 reference

12 December 2020

Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children

1 reference

12 December 2020

Inhibition of acid secretion in isolated gastric glands by substituted benzimidazoles

1 reference

12 December 2020

Vitamin B12 levels during prolonged treatment with proton pump inhibitors

1 reference

12 December 2020

Effects of a proton-pump inhibitor in cystic fibrosis

1 reference

12 December 2020

Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.

1 reference

12 December 2020

Fundic gland polyps developing during omeprazole therapy

1 reference

12 December 2020

Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders

1 reference

12 December 2020

Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat.

1 reference

12 December 2020

10.2165/00128072-200305010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1015859829

0 references

1 reference